Literature DB >> 14763076

The peritoneal membrane: a dynamic dialysis membrane in children.

Michel Fischbach1, Börje Haraldsson, Pauline Helms, Stéphanie Danner, Vincent Laugel, Joëlle Terzic.   

Abstract

Peritoneal dialysis prescription in children should be individualized--based not only on numerical targets (Kt/Vurea, Kcreat), but also on consideration of the peritoneal membrane, a dynamic dialysis membrane. In fact, the effective peritoneal surface area is at least a triple entity: an anatomic area, a contact area, and an exchange area. The anatomic area appears to be twice as large in infants as in adults if expressed per kilogram of body weight (BW), although the area is independent of age if expressed per square meter of body surface area (BSA). Therefore, scaling of the intraperitoneal fill volume (IPV) by BSA in square meters is necessary to avoid a low IPV/area ratio, which results in a functionally "hyperpermeable" peritoneal exchange. The contact area (the wetted membrane) is only a fraction of the anatomic area--that is, 30%-60% in humans (by computed tomography). Contact area depends on a variety of factors, such as posture and fill volume, that affect the degree of recruitment of membrane contact area. The exchange area is influenced by both the anatomic are and the contact area. However, it is mainly governed by the specific vascular area as determined by the peritoneal vascular perfusion and the capillaries available for exchange. Vascular area is dynamically affected by a variety of factors, such as the composition of the peritoneal dialysis fluid, the fill volume, and possible inflammatory agents.

Entities:  

Mesh:

Year:  2003        PMID: 14763076

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  4 in total

Review 1.  Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume.

Authors:  Michel Fischbach; Ariane Zaloszyc; Betti Schaefer; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2013-08-02       Impact factor: 3.714

Review 2.  Pathogenesis and treatment of peritoneal membrane failure.

Authors:  Ramesh Saxena
Journal:  Pediatr Nephrol       Date:  2007-09-21       Impact factor: 3.714

3.  Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5).

Authors:  Aleksandra M Zurowska; Michel Fischbach; Alan R Watson; Alberto Edefonti; Constantinos J Stefanidis
Journal:  Pediatr Nephrol       Date:  2012-10-09       Impact factor: 3.714

4.  BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].

Authors:  Barbara Nau; Claus P Schmitt; Margarida Almeida; Klaus Arbeiter; Gianluigi Ardissino; Klaus E Bonzel; Alberto Edefonti; Michel Fischbach; Karin Haluany; Joachim Misselwitz; Markus J Kemper; Kai Rönnholm; Simone Wygoda; Franz Schaefer
Journal:  BMC Nephrol       Date:  2004-10-14       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.